Abstract
Prognosis (Gk. prognosis) means to know in advance. To predict (Lat. praedicere) means to state, tell about or make known in advance. Prediction is the more technical term compared to prognosis. Prognosis is a prediction especially of the probable course of a disease. This makes clear that in prediction research we deal with probabilities. One aim of this kind of research is to increase the probability of correct prediction. The clinical aim is to improve the course of illness by tailoring the treatment to the individual patient.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Key selected references.
Awad AG (1993) Methodological and design issues in clinical trials of new neuroleptics: an overview. Br J Psychiatry 163[Suppl 22]: 51–57.
Carpenter WT, Heinrichs DW, Hanlon TE (1981) Methodologic standards for treatment outcome research in schizophrenia. Am J Psychiatry 138: 465–471.
Clements K, Turpin G (1992) Vulnerability models and schizophrenia: the assessment and prediction of relapse. In: Birchwood M, Tarrier N (eds) Innovations in the psychological management of schizophrenia. Wiley, Chichester New York Brisbane Toronto Singapore, pp 21–47.
Engel GL (1980) The clinical application of the biopsycho-social model. Am J Psychiatry 137: 535–544.
Gaebel W, Renfordt E (eds) (1989) Objective methods for behavioral analysis in psychiatry and psychopharmacology — examples and concepts. Pharmacopsychiatry 22[Suppl]: 1–50.
Helmchen H, Gaebel W (1987) Strategies of clinical research on neurobiological determinants of psychosis. Psychiatr Dev 5: 51–62.
Hsiao JK, Bartko JJ, Potter WZ (1989) Diagnosing diagnoses. Receiver operating characteristic methods and psychiatry. Arch Gen Psychiatry 46: 664–667.
Kissling W (ed) (1991) Guidelines for neuroleptic relapse prevention in schizophrenia. Springer, Berlin Heidelberg New York Tokyo.
May PRA, Van Putten T, Yale C, Potepan P, Jenden DJ, Fairchild MD, Goldstein MJ, Dixon WJ (1976) Predicting individual responses to drug treatment in schizophrenia: a test dose model. J Nerv Ment Dis 162: 177–183.
May PRA, Goldberg SC (1978) Prediction of schizophrenic patients’ response to pharmacotherapy. In: Lipton MA, Dimascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1139–1153.
Nuechterlein KH (1987) Vulnerability models for schizophrenia: state of the art. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the causes of schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 297–316.
Van Praag HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML (1987) Denosologization of biological psychiatry or the specifity of 5-HT disturbances in psychiatric disorders. J Affect Disord 13: 1–8.
Woggon B, Baumann U (1983) Multimethodological approach in psychiatric predictor research. Pharmacopsychiatry 16: 175–178.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Wien
About this paper
Cite this paper
Gaebel, W., Awad, A.G. (1994). Prediction research in neuroleptic therapy — future directions. In: Gaebel, W., Awad, A.G. (eds) Prediction of Neuroleptic Treatment Outcome in Schizophrenia. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6636-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6636-9_18
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82602-7
Online ISBN: 978-3-7091-6636-9
eBook Packages: Springer Book Archive